Human Papillomavirus Vaccination and Pap Smear Uptake among Young Women in the United States: Role of Provider and Patient

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: It as been reported that Pap smear use is higher among U.S. women who received the human papillomavirus (HPV) vaccine than unvaccinated women. This study assessed the role of provider and patient in the difference of Pap smear use by vaccination status. Methods: We conducted a cross-sectional study of 5416 young women (21-30 years of age) with detailed information on Pap smear use and HPV vaccination status from the National Health Interview Survey (NHIS) 2013-2015. Vaccinated women received at least one dose of HPV vaccine. Main outcomes included Pap smear in the past year, provider's recommendation for Pap smear, and patient-initiated Pap smear. Results: The prevalence of Pap smear in the past year was much higher among vaccinated women than unvaccinated women (67.5% vs. 52.8%, p < 0.001). Compared with unvaccinated women, vaccinated women were more likely to receive a provider's recommendation for Pap testing (60.8% vs. 50.8%, p < 0.001), to obtain Pap testing after receiving a provider's recommendation (75.1% vs. 67.9%, p = 0.004), and to initiate Pap testing themselves (57.7% vs. 38.2%, p < 0.001). However, among women who visited an obstetrician/gynecologist (OB/GYN) in the past year, the positive association between HPV vaccination and Pap smear recommendation and uptake vanished. Conclusions: Unvaccinated women who have not visited an OB/GYN in the past year are less likely to receive a recommendation for Pap testing from their providers or to initiate Pap testing themselves without a provider's recommendation. They should be encouraged to visit an OB/GYN provider for cervical cancer screening.

Original languageEnglish (US)
Pages (from-to)1114-1122
Number of pages9
JournalJournal of Women's Health
Volume26
Issue number10
DOIs
StatePublished - Oct 1 2017

Fingerprint

Papanicolaou Test
Vaccination
Papillomavirus Vaccines
Health Surveys
Early Detection of Cancer
Uterine Cervical Neoplasms
Cross-Sectional Studies
Interviews

Keywords

  • cancer screeninghealth communication
  • cervical cancer
  • human papillomavirus vaccine
  • papanicolaou test

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{2ad1abfc4d294379b7b636842fbfcab3,
title = "Human Papillomavirus Vaccination and Pap Smear Uptake among Young Women in the United States: Role of Provider and Patient",
abstract = "Background: It as been reported that Pap smear use is higher among U.S. women who received the human papillomavirus (HPV) vaccine than unvaccinated women. This study assessed the role of provider and patient in the difference of Pap smear use by vaccination status. Methods: We conducted a cross-sectional study of 5416 young women (21-30 years of age) with detailed information on Pap smear use and HPV vaccination status from the National Health Interview Survey (NHIS) 2013-2015. Vaccinated women received at least one dose of HPV vaccine. Main outcomes included Pap smear in the past year, provider's recommendation for Pap smear, and patient-initiated Pap smear. Results: The prevalence of Pap smear in the past year was much higher among vaccinated women than unvaccinated women (67.5{\%} vs. 52.8{\%}, p < 0.001). Compared with unvaccinated women, vaccinated women were more likely to receive a provider's recommendation for Pap testing (60.8{\%} vs. 50.8{\%}, p < 0.001), to obtain Pap testing after receiving a provider's recommendation (75.1{\%} vs. 67.9{\%}, p = 0.004), and to initiate Pap testing themselves (57.7{\%} vs. 38.2{\%}, p < 0.001). However, among women who visited an obstetrician/gynecologist (OB/GYN) in the past year, the positive association between HPV vaccination and Pap smear recommendation and uptake vanished. Conclusions: Unvaccinated women who have not visited an OB/GYN in the past year are less likely to receive a recommendation for Pap testing from their providers or to initiate Pap testing themselves without a provider's recommendation. They should be encouraged to visit an OB/GYN provider for cervical cancer screening.",
keywords = "cancer screeninghealth communication, cervical cancer, human papillomavirus vaccine, papanicolaou test",
author = "Fangjian Guo and Hirth, {Jacqueline M.} and Berenson, {Abbey B.}",
year = "2017",
month = "10",
day = "1",
doi = "10.1089/jwh.2017.6424",
language = "English (US)",
volume = "26",
pages = "1114--1122",
journal = "Journal of Women's Health",
issn = "1540-9996",
publisher = "Mary Ann Liebert Inc.",
number = "10",

}

TY - JOUR

T1 - Human Papillomavirus Vaccination and Pap Smear Uptake among Young Women in the United States

T2 - Role of Provider and Patient

AU - Guo, Fangjian

AU - Hirth, Jacqueline M.

AU - Berenson, Abbey B.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Background: It as been reported that Pap smear use is higher among U.S. women who received the human papillomavirus (HPV) vaccine than unvaccinated women. This study assessed the role of provider and patient in the difference of Pap smear use by vaccination status. Methods: We conducted a cross-sectional study of 5416 young women (21-30 years of age) with detailed information on Pap smear use and HPV vaccination status from the National Health Interview Survey (NHIS) 2013-2015. Vaccinated women received at least one dose of HPV vaccine. Main outcomes included Pap smear in the past year, provider's recommendation for Pap smear, and patient-initiated Pap smear. Results: The prevalence of Pap smear in the past year was much higher among vaccinated women than unvaccinated women (67.5% vs. 52.8%, p < 0.001). Compared with unvaccinated women, vaccinated women were more likely to receive a provider's recommendation for Pap testing (60.8% vs. 50.8%, p < 0.001), to obtain Pap testing after receiving a provider's recommendation (75.1% vs. 67.9%, p = 0.004), and to initiate Pap testing themselves (57.7% vs. 38.2%, p < 0.001). However, among women who visited an obstetrician/gynecologist (OB/GYN) in the past year, the positive association between HPV vaccination and Pap smear recommendation and uptake vanished. Conclusions: Unvaccinated women who have not visited an OB/GYN in the past year are less likely to receive a recommendation for Pap testing from their providers or to initiate Pap testing themselves without a provider's recommendation. They should be encouraged to visit an OB/GYN provider for cervical cancer screening.

AB - Background: It as been reported that Pap smear use is higher among U.S. women who received the human papillomavirus (HPV) vaccine than unvaccinated women. This study assessed the role of provider and patient in the difference of Pap smear use by vaccination status. Methods: We conducted a cross-sectional study of 5416 young women (21-30 years of age) with detailed information on Pap smear use and HPV vaccination status from the National Health Interview Survey (NHIS) 2013-2015. Vaccinated women received at least one dose of HPV vaccine. Main outcomes included Pap smear in the past year, provider's recommendation for Pap smear, and patient-initiated Pap smear. Results: The prevalence of Pap smear in the past year was much higher among vaccinated women than unvaccinated women (67.5% vs. 52.8%, p < 0.001). Compared with unvaccinated women, vaccinated women were more likely to receive a provider's recommendation for Pap testing (60.8% vs. 50.8%, p < 0.001), to obtain Pap testing after receiving a provider's recommendation (75.1% vs. 67.9%, p = 0.004), and to initiate Pap testing themselves (57.7% vs. 38.2%, p < 0.001). However, among women who visited an obstetrician/gynecologist (OB/GYN) in the past year, the positive association between HPV vaccination and Pap smear recommendation and uptake vanished. Conclusions: Unvaccinated women who have not visited an OB/GYN in the past year are less likely to receive a recommendation for Pap testing from their providers or to initiate Pap testing themselves without a provider's recommendation. They should be encouraged to visit an OB/GYN provider for cervical cancer screening.

KW - cancer screeninghealth communication

KW - cervical cancer

KW - human papillomavirus vaccine

KW - papanicolaou test

UR - http://www.scopus.com/inward/record.url?scp=85031671804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031671804&partnerID=8YFLogxK

U2 - 10.1089/jwh.2017.6424

DO - 10.1089/jwh.2017.6424

M3 - Article

C2 - 28841084

AN - SCOPUS:85031671804

VL - 26

SP - 1114

EP - 1122

JO - Journal of Women's Health

JF - Journal of Women's Health

SN - 1540-9996

IS - 10

ER -